Abstract Free Full Text Similar Articles Mail to Author

¹Assistant Prof. MD., Ondokuz Mayis University, Ophthalmology Department, Samsun Turkey
²Prof. MD., Ondokuz Mayis University, Ophthalmology Department, Samsun, Turkey DOI : 10.37844/glauc.cat.2020.15.10 W e aimed to report a case of bilateral acute iris transillumination and pigment dispersion related to oral moxifl oxacin that used a higher dose than recommended. A 43-year-old woman who presented with redness, pain, blurred vision, and high intraocular pressure (IOP) 10 hours after taking six oral moxifl oxacin tablets because of pneumonia was referred to our clinic for differential diagnosis. Slit-lamp examination revealed conjunctival hyperemia, endothelial dusting, fl oating anterior chamber pigments, and diffuse transillumination for both irises. IOP was in the normal range with both topical and systemic antiglaucomatous treatment. The patient experienced several fl are-ups within three months, especially in the fi rst month. The pigment cells decreased in both the anterior chamber and trabecular meshwork, however, diffuse transillumination is still continuing in both eyes. Although the relationship between oral fl uoroquinolones and uveitis is still controversial, the presented case with severe signs and symptoms shortly after taking high dose oral moxifl oxacin supports this relation. Keywords : Oral fluoroquinolones, oral moxifl oxacin, bilateral acute iris transillumination, uveitis